green cross
Four-Strain Seasonal Flu Vaccine Approved in Korea
The health authority of South Korea has approved the first Korean-made vaccine to cover four influenza strains.
Green Cross To Build New Cell Therapy Manufacturing Facility In China
The new Green Cross cell therapy manufacturing facility will be located at the Guian New Area in the Guizhou province.
Green Cross Biologics To Enter Russian Market
A partnership with Russian pharmaceutical Nanolek sees Green Cross' biologics enter the rapidly growing Russian market.
Green Cross Expands Cell Therapy Business In China
Green Cross has signed an MOU to expand its cell therapy facilities in Guizhou, China.
South Korean FDA Approval For Green Cross’ Neulapeg®
Green Cross receives regulatory approval for its once-per-cycle dose neutropenia drug, Neulapeg®.
Green Cross Expands Biologics To North America
The proposed US$163 million Green Cross facility will have the capacity to fractionate up to one million liters of plasma a year.
